A comparative analysis of the impact of modern antiepileptic drugs on cognitive status and psychoneurological outcomes in patients with post-traumatic epilepsy

Introduction. Posttraumatic epilepsy (PTE) is a serious chronic complication of traumatic brain injury, in which persistent cognitive impairment is one of the most disabling consequences. Despite its significant impact on quality of life and rehabilitation prognosis, cognitive assessment is often neglected in routine clinical practice, with a standard approach focused primarily on seizure control. Aim. To conduct a comparative analysis of cognitive function dynamics, assessed using a standardized scale, in patients with PTE during monotherapy with various antiepileptic drugs – valproic acid, oxcarbazepine, levetiracetam, and lamotrigine – to determine the optimal therapy in terms of neurocognitive outcomes. Materials and methods. A retrospective study was conducted in the neurology department. Data from 40 patients with a verified diagnosis of PTE were included in the analysis. A comprehensive examination included neuroimaging (MRI), electroencephalographic (EEG) monitoring, and a mandatory assessment of global cognitive status using the Mini-Mental State Examination (MMSE). MMSE scores were compared during periods of stable monotherapy with each of the indicated antiepileptic drugs. Results. The results revealed statistically significant improvements in cognitive performance with lamotrigine therapy. The average MMSE score was 27.7±0.3, which is 4 points higher than the result recorded with valproic acid therapy (23.7±0.3). This improvement upgrades the patient's cognitive status from moderate to mild, a clinically significant achievement potentially leading to increased functional independence. Oxcarbazepine and levetiracetam therapy showed intermediate but less pronounced results. Keywords: post-traumatic epilepsy, cognitive impairment, antiepileptic drugs, lamotrigine, neuropsychological status, quality of life, personalized therapy.

Authors

Publication Details

Journal
Clinical review for general practice
Published
2026-11-16
DOI
https://doi.org/10.47407/kr2026.7.9.00940
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A comparative analysis of the impact of modern antiepileptic drugs on cognitive status and psychoneurological outcomes in patients with post-traumatic epilepsy

Е.Р. ТОКАРЕВА
Clinical review for general practice
Epilepsy research and treatment
article

A comparative analysis of the impact of modern antiepileptic drugs on cognitive status and psychoneurological outcomes in patients with post-traumatic epilepsy

Е.Р. ТОКАРЕВА
article en

Abstract

Introduction. Posttraumatic epilepsy (PTE) is a serious chronic complication of traumatic brain injury, in which persistent cognitive impairment is one of the most disabling consequences. Despite its significant impact on quality of life and rehabilitation prognosis, cognitive assessment is often neglected in routine clinical practice, with a standard approach focused primarily on seizure control. Aim. To conduct a comparative analysis of cognitive function dynamics, assessed using a standardized scale, in patients with PTE during monotherapy with various antiepileptic drugs – valproic acid, oxcarbazepine, levetiracetam, and lamotrigine – to determine the optimal therapy in terms of neurocognitive outcomes. Materials and methods. A retrospective study was conducted in the neurology department. Data from 40 patients with a verified diagnosis of PTE were included in the analysis. A comprehensive examination included neuroimaging (MRI), electroencephalographic (EEG) monitoring, and a mandatory assessment of global cognitive status using the Mini-Mental State Examination (MMSE). MMSE scores were compared during periods of stable monotherapy with each of the indicated antiepileptic drugs. Results. The results revealed statistically significant improvements in cognitive performance with lamotrigine therapy. The average MMSE score was 27.7±0.3, which is 4 points higher than the result recorded with valproic acid therapy (23.7±0.3). This improvement upgrades the patient's cognitive status from moderate to mild, a clinically significant achievement potentially leading to increased functional independence. Oxcarbazepine and levetiracetam therapy showed intermediate but less pronounced results. Keywords: post-traumatic epilepsy, cognitive impairment, antiepileptic drugs, lamotrigine, neuropsychological status, quality of life, personalized therapy.

Clinical review for general practiceVol. 7(9)
Good health and well-being
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon